CD63 and breast cancer: Then, we treated ERα‐positive BCs or breast cancer organoids with CAF‐derived exosomes and observed that CD63+ CAF‐derived exosomes could induce ERα downregulation (Figure 4C,D; Figure S3B,C, Supporting Information).